First-in-Human Heart Pump Implant Study
Part of Heart & circulation clinical trials.
This trial tests a new tiny heart pump called the Icoms Flowmaker for patients with severe heart failure who cannot have a standard heart pump. The device may help your heart pump blood better and improve your ability to do daily activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Severe heart failure (ejection fraction ≤35%) that hasn't improved with medicines
- Your heart is enlarged enough for the pump (specific measurements required)
- You have a contraindication to standard heart pumps OR high risk from the driveline (the tube connecting the pump to the outside), OR you're waiting for a heart transplant but temporarily cannot have one
- You do not have active infections, blood clots, or severe lung, liver, or kidney disease
- You live with someone who can help care for you after implant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This study tests a new type of heart pump (the DuoCor 2) designed to support both the left and right sides of the heart. The pump is implanted during surgery and may help people with very advanced heart failure feel better and live longer.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.